digital therapeutics

The startup said that the seed funding will support continued development of Regulora, its behavioral intervention delivered through a mobile platform.

Vetting digital health products for distribution and reimbursement is another step forward for novel digital treatments hoping to stand alongside traditional biologics.

A trend in health tech companies going public leads to a public conversation on terminology.

CEO and President Dr. Corey McCann said that Somryst, a digital treatment for chronic insomnia and depression, is the first software as a medical device product to be submitted through the regulator's pilot pathway. 

In July, MobiHealthNews will focus on how pharma companies are using digital tools for R&D, real-world evidence collection and exploring new therapeutics. 

The announcement is yet another milestone on the road to adoption and reimbursement of digital therapies, Big Health CEO Peter Hames said.

At BIO 2019, Sanofi's chief medical and digital officer advised fellow pharma leaders on embracing new technologies and preparing for the challenges they'll bring.

The pharmacy benefit manager will be vetting each of the tools featured within the new formulary for therapeutic value, usability, security, privacy and cost effectiveness.

Remember that you are partners who have come together because you each have unique skills that the other cannot replicate on their own.

Longwall Venture Partners, IQ Capital and Martlet participated in the round.